Alvotech is a biotech company, founded by Róbert Wessman, focused solely on the development and manufacture of biosimilar medicines for patients worldwide. Alvotech seeks to be a global leader in the biosimilar space by delivering high quality, cost-effective products, and services, enabled by a fully integrated approach and broad in-house capabilities.

Alvotech’s true purpose is to make people’s lives better by producing high quality medicines that help people live healthier, and more active lives.

Alvotech operates on the principle that if there is a cure, we believe it should be available for everyone and not just the privileged few.

Biosimilars offer great hope and promise to people suffering from serious medical conditions and at Alvotech we aim to deliver on that promise.

Alvotech's goal is to be a global leader in the biosimilar space and to deliver high quality cost competitive products to patients worldwide.